Modern women choose contraceptive vaginal ring
暂无分享,去创建一个
[1] T. Anothaisintawee,et al. Association of Hormonal Contraceptive Use With Adverse Health Outcomes , 2022, JAMA network open.
[2] A. Edelman,et al. Contraception Selection, Effectiveness, and Adverse Effects: A Review. , 2021, JAMA.
[3] S. Achilles,et al. Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world , 2021, Contraception.
[4] K. Workowski,et al. Sexually Transmitted Infections Treatment Guidelines, 2021 , 2021, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[5] J. H. van de Wijgert,et al. Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis , 2021, Frontiers in Global Women's Health.
[6] S. Asthana,et al. Oral contraceptives use and risk of cervical cancer-A systematic review & meta-analysis. , 2020, European journal of obstetrics, gynecology, and reproductive biology.
[7] Mark C. Wheldon,et al. Estimating progress towards meeting women’s contraceptive needs in 185 countries: A Bayesian hierarchical modelling study , 2020, PLoS medicine.
[8] A. van der Straten,et al. Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis , 2019, PloS one.
[9] K. Underhill,et al. A Qualitative Systematic Review of Women's Experiences Using Contraceptive Vaginal Rings: Implications for New Technologies. , 2019, Perspectives on sexual and reproductive health.
[10] J. H. van de Wijgert,et al. Contraceptive rings promote vaginal lactobacilli in a high bacterial vaginosis prevalence population: A randomised, open-label longitudinal study in Rwandan women , 2018, PloS one.
[11] J. H. van de Wijgert,et al. High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda , 2018, PloS one.
[12] J. H. van de Wijgert,et al. A randomised trial of a contraceptive vaginal ring in women at risk of HIV infection in Rwanda: Safety of intermittent and continuous use , 2018, PloS one.
[13] A. López-Picado,et al. Efficacy and side-effects profile of the ethinylestradiol and etonogestrel contraceptive vaginal ring: a systematic review and meta-analysis , 2017, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[14] P. Su,et al. Efficacy and safety of the contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive in Chinese women: a 1-year randomised trial , 2016, European journal of contraception & reproductive health care.
[15] J. Jensen,et al. Evaluating the efficacy and safety of a progestin- and estrogen-releasing ethylene vinyl acetate copolymer contraceptive vaginal ring , 2014, Expert opinion on drug safety.
[16] M. Guida,et al. Sexual life impact evaluation of different hormonal contraceptives on the basis of their methods of administration , 2014, Archives of Gynecology and Obstetrics.
[17] A. Chauhan,et al. Multicenter Study of Contraceptive Vaginal Ring (NuvaRing®) in Normal Daily Practice in Indian Women , 2014, The Journal of Obstetrics and Gynecology of India.
[18] N. Persico,et al. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study. , 2014, The journal of sexual medicine.
[19] J. M. Marín,et al. Vaginal health in contraceptive vaginal ring users – A review , 2013, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[20] A. Buysse,et al. Relation of androgen receptor sensitivity and mood to sexual desire in hormonal contraception users. , 2012, Contraception.
[21] J. Esplugues,et al. Is the vagina an adequate route for the administration of hormonal contraceptives? , 2010, Current drug metabolism.
[22] G. Merki-Feld,et al. Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use , 2010, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[23] M. Consolaro,et al. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring? , 2010, Contraception.
[24] P. Inki,et al. Efficacy of contraceptive methods: A review of the literature , 2010, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[25] N. Mendoza,et al. Self-described impact of noncompliance among users of a combined hormonal contraceptive method. , 2008, Contraception.
[26] I. Milsom,et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone. , 2006, Contraception.
[27] R. Cagiano,et al. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. , 2006, Contraception.
[28] C. Westhoff,et al. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. , 2006, Contraception.
[29] F. Roumen,et al. The combined contraceptive vaginal ring (NuvaRing®): First experience in daily clinical practice in The Netherlands , 2006, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[30] M. Guida,et al. Effects of two types of hormonal contraception--oral versus intravaginal--on the sexual life of women and their partners. , 2005, Human reproduction.
[31] D. Mishell,et al. Contraceptive vaginal rings releasing Nestorone and ethinylestradiol: a 1-year dose-finding trial. , 2005, Contraception.
[32] D. Apter,et al. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. , 2001, Human reproduction.
[33] C. Timmer,et al. Pharmacokinetics of Etonogestrel and Ethinylestradiol Released from a Combined Contraceptive Vaginal Ring , 2000, Clinical pharmacokinetics.
[34] C. Loge,et al. Development and Validation of an Acceptability and Satisfaction Questionnaire for a Contraceptive Vaginal Ring, NuvaRing® , 2012, PharmacoEconomics.